Intern. Med. volume 35, issue 2, P85-86 1996 DOI: 10.2169/internalmedicine.35.85 View full text
|
|
Share
Masao NAKAGAWA

Abstract: Radiolabelled MIBG(metaiodobenzylguanidine) was first developed by Wieland et al as a candidate of agents to make it possible to evaluate the in vivo function of sympathetic nerve (1). It is one of the analogs of guanethidine which is an